New studies reveal Curcuma kwangsiensis radix’s antiplatelet properties via three novel sesquiterpenoids, with AI models predicting thrombin inhibition and WHO endorsing standardized research. B...
New research reveals how climate variability affects CKR’s phytochemical profile, prompting calls for adaptive quality markers in China’s TCM standardization efforts. Recent studies show r...
New research shows significant regional differences in bioactive compounds of Curcumae kwangsiensis radix, with Guangxi varieties showing superior cardiovascular benefits. Cutting-edge studies reveal ...
Emerging technologies address standardization challenges for CKR, with new research confirming its antiplatelet effects and regional quality disparities. Cutting-edge technologies are transforming qua...
New research reveals how geographical origin affects bioactive compounds in Curcumae kwangsiensis radix, with implications for standardized herbal medicine and thrombosis prevention. Cutting-edge rese...
New research reveals Guangxi-sourced CKR has 15% higher curcumin content than Yunnan’s, with distinct pharmacological effects on thrombosis through spectrum-effect relationship analysis. Groundb...